Cardiac magnetic resonance (CMR) it is a technique without radiation, which is considered the gold-standard for the evaluation of cardiac anatomy, function and even tissue composition. The RESILIENCE trial will use CMR as the main outcome measure methodology, and patients enrolled in the trial will undergo 3 scans across the duration of the study.
Multinational, prospective, proof of concept phase II, double-blinded, sham-controlled, randomized clinical trial (RCT) to evaluate the efficacy and safety of Remote Ischaemic Conditioning (RIC) in Lymphoma patients receiving anthracyclines. Patients scheduled to undergo ≥5 chemotherapy cycles will be eligible.
On Thursday June 1st Hospital Universitario 12 de Octubre in Madrid has joined the RESILIENCE project and it will most probably begin to recruit patients in the coming weeks. Hospital 12 de Octubre obtained in 2020 the Best in Class (BIC) Award for the Best Service in Hematology and Hemotherapy, the BIC for the Best Service […]
